Cellmid has 35% of the Australian pharmacies as customers. They are about to launch into the Japanese pharmacy market. A good move by the looks of things. http://news.medill.northwestern.edu/chicago/tokyo-pharmacies-cater-to-foreign-shoppers/
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game